SPO11
Basic information
Region (hg38): 20:57329803-57343994
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (37 variants)
- not_provided (2 variants)
- Non-obstructive_azoospermia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPO11 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012444.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 36 | 38 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 1 | 36 | 1 | 1 |
Highest pathogenic variant AF is 0.0000063700923
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SPO11 | protein_coding | protein_coding | ENST00000371263 | 13 | 14236 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.45e-8 | 0.605 | 125687 | 0 | 61 | 125748 | 0.000243 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.975 | 165 | 204 | 0.808 | 0.00000991 | 2595 |
| Missense in Polyphen | 36 | 51.998 | 0.69233 | 674 | ||
| Synonymous | -0.801 | 79 | 70.5 | 1.12 | 0.00000355 | 728 |
| Loss of Function | 1.17 | 15 | 20.8 | 0.722 | 9.28e-7 | 282 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000395 | 0.000390 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000116 | 0.000109 |
| Finnish | 0.0000929 | 0.0000924 |
| European (Non-Finnish) | 0.000404 | 0.000396 |
| Middle Eastern | 0.000116 | 0.000109 |
| South Asian | 0.0000364 | 0.0000327 |
| Other | 0.000167 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a topoisomerase 6 complex specifically required for meiotic recombination. Together with TOP6BL, mediates DNA cleavage that forms the double-strand breaks (DSB) that initiate meiotic recombination. The complex promotes relaxation of negative and positive supercoiled DNA and DNA decatenation through cleavage and ligation cycles. Essential for the phosphorylation of SMC3, HORMAD1 and HORMAD2. {ECO:0000250|UniProtKB:Q9WTK8}.;
- Pathway
- Reproduction;Meiotic recombination;Meiosis;Cell Cycle
(Consensus)
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- loftool
- 0.908
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.46
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- Y
- hipred_score
- 0.585
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0848
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spo11
- Phenotype
- hearing/vestibular/ear phenotype; immune system phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- meiotic DNA double-strand break processing;DNA catabolic process, endonucleolytic;ovarian follicle development;synaptonemal complex assembly;reciprocal meiotic recombination;male meiosis I;spermatogenesis;spermatid development;female gamete generation;protein localization to chromosome;meiotic DNA double-strand break formation;meiotic telomere clustering;oogenesis;double-strand break repair involved in meiotic recombination
- Cellular component
- chromosome, telomeric region
- Molecular function
- DNA binding;DNA topoisomerase type II (ATP-hydrolyzing) activity;protein binding;ATP binding;endodeoxyribonuclease activity, producing 3'-phosphomonoesters;metal ion binding